Kenneth A. Schwartz

2.0k total citations
58 papers, 1.5k citations indexed

About

Kenneth A. Schwartz is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Kenneth A. Schwartz has authored 58 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 12 papers in Cardiology and Cardiovascular Medicine and 10 papers in Surgery. Recurrent topics in Kenneth A. Schwartz's work include Platelet Disorders and Treatments (12 papers), Antiplatelet Therapy and Cardiovascular Diseases (11 papers) and Diet and metabolism studies (7 papers). Kenneth A. Schwartz is often cited by papers focused on Platelet Disorders and Treatments (12 papers), Antiplatelet Therapy and Cardiovascular Diseases (11 papers) and Diet and metabolism studies (7 papers). Kenneth A. Schwartz collaborates with scholars based in United States, Czechia and Germany. Kenneth A. Schwartz's co-authors include Dianne E. Schwartz, Howard T. Chang, Anthony DeFranco, Lana Kaiser, Kimberly Barber, L. Karl Olson, Gary Ferenchick, John M. Davis, Mathew J. Reeves and Michael A. Scott and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Radiology.

In The Last Decade

Kenneth A. Schwartz

55 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenneth A. Schwartz United States 22 505 343 248 231 230 58 1.5k
Juana Vallés Spain 19 608 1.2× 401 1.2× 275 1.1× 199 0.9× 244 1.1× 65 1.7k
M.A. Barradas United Kingdom 23 460 0.9× 323 0.9× 395 1.6× 208 0.9× 252 1.1× 72 1.7k
Giuseppe G. Nenci Italy 25 621 1.2× 491 1.4× 417 1.7× 219 0.9× 265 1.2× 100 1.9k
L B Safier United States 15 428 0.8× 519 1.5× 216 0.9× 276 1.2× 301 1.3× 25 1.7k
Marta Brambilla Italy 24 362 0.7× 397 1.2× 222 0.9× 111 0.5× 424 1.8× 78 1.8k
Ahmed Hasan United States 20 686 1.4× 450 1.3× 490 2.0× 118 0.5× 475 2.1× 46 2.5k
M. Cortellaro Italy 21 376 0.7× 442 1.3× 370 1.5× 63 0.3× 121 0.5× 70 1.4k
Paul C. Armstrong United Kingdom 23 543 1.1× 369 1.1× 219 0.9× 74 0.3× 234 1.0× 50 1.4k
John C. Hoak United States 23 661 1.3× 414 1.2× 507 2.0× 231 1.0× 427 1.9× 57 2.3k
Zhongren Ding China 18 462 0.9× 289 0.8× 245 1.0× 68 0.3× 386 1.7× 40 1.6k

Countries citing papers authored by Kenneth A. Schwartz

Since Specialization
Citations

This map shows the geographic impact of Kenneth A. Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth A. Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth A. Schwartz more than expected).

Fields of papers citing papers by Kenneth A. Schwartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth A. Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth A. Schwartz. The network helps show where Kenneth A. Schwartz may publish in the future.

Co-authorship network of co-authors of Kenneth A. Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth A. Schwartz. A scholar is included among the top collaborators of Kenneth A. Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth A. Schwartz. Kenneth A. Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schwartz, Kenneth A., et al.. (2019). ACTR-22. INITIAL TREATMENT OF GBM WITH A KETOGENIC DIET ALONG WITH RADIATION AND CHEMOTHERAPY: CLINICAL OUTCOMES. Neuro-Oncology. 21(Supplement_6). vi17–vi17.
2.
Schwartz, Kenneth A., et al.. (2018). Investigating the Ketogenic Diet As Treatment for Primary Aggressive Brain Cancer: Challenges and Lessons Learned. Frontiers in Nutrition. 5. 11–11. 38 indexed citations
4.
Kurniali, Peter C., et al.. (2013). Incidence Of Hospital Acquired Anemia. Blood. 122(21). 1700–1700. 2 indexed citations
5.
Chang, Howard T., L. Karl Olson, & Kenneth A. Schwartz. (2013). Ketolytic and glycolytic enzymatic expression profiles in malignant gliomas: implication for ketogenic diet therapy. Nutrition & Metabolism. 10(1). 47–47. 80 indexed citations
6.
Hofmann, Martin, Ludger Große‐Hovest, Elwira Pyż, et al.. (2012). Generation, selection and preclinical characterization of an Fc-optimized FLT3 antibody for the treatment of myeloid leukemia. Leukemia. 26(6). 1228–1237. 61 indexed citations
7.
Noel, Mary, et al.. (2010). Weight Loss: An Important but Often Overlooked Clue for the Diagnosis of Cancer. Blood. 116(21). 2552–2552. 1 indexed citations
8.
Kaiser, Lana, et al.. (2009). Iron sufficient to cause hepatic fibrosis and ascites does not cause cardiac arrhythmias in the gerbil. Translational research. 154(4). 202–213. 19 indexed citations
9.
Schwartz, Kenneth A., et al.. (2008). Non-compliance is the predominant cause of aspirin resistance in chronic coronary arterial disease patients. Journal of Translational Medicine. 6(1). 46–46. 56 indexed citations
10.
Schwartz, Kenneth A., Dianne E. Schwartz, Kimberly Barber, Matthew B. Reeves, & Anthony DeFranco. (2007). Non-Compliance Is the Predominant Cause of Aspirin Resistance.. Blood. 110(11). 932–932. 1 indexed citations
11.
Malinin, Alex I., Alex Pokov, Anthony DeFranco, et al.. (2006). Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12® rapid analyzer: The VERIfy Thrombosis risk ASsessment (VERITAS) study. Thrombosis Research. 119(3). 277–284. 184 indexed citations
12.
Davis, John M., et al.. (2005). MHC Class I–Associated Peptides Identified From Normal Platelets and From Individuals With Idiopathic Thrombocytopenic Purpura. Human Immunology. 66(8). 874–883. 11 indexed citations
13.
Schwartz, Kenneth A., et al.. (2005). Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction. The American Journal of Cardiology. 95(8). 973–975. 163 indexed citations
14.
Scott, Michael A., Lana Kaiser, John M. Davis, & Kenneth A. Schwartz. (2002). Development of a sensitive immunoradiometric assay for detection of platelet surface-associated immunoglobulins in thrombocytopenic dogs. American Journal of Veterinary Research. 63(1). 124–129. 19 indexed citations
15.
Schwartz, Kenneth A.. (2000). GESTATIONAL THROMBOCYTOPENIA AND IMMUNE THROMBOCYTOPENIAS IN PREGNANCY. Hematology/Oncology Clinics of North America. 14(5). 1101–1116. 11 indexed citations
16.
Ferenchick, Gary, et al.. (1995). Anabolic‐Androgenic steroid abuse in weight lifters: Evidence for activation of the hemostatic system. American Journal of Hematology. 49(4). 282–288. 56 indexed citations
17.
Schwartz, Kenneth A., et al.. (1993). Iron-Induced Myocardial and Hepatic Lysosomal Abnormalities in the Guinea Pig. Toxicologic Pathology. 21(3). 321–326. 11 indexed citations
18.
Schwartz, Kenneth A.. (1988). Platelet antibody: Review of detection methods. American Journal of Hematology. 29(2). 106–114. 22 indexed citations
19.
Camara, Daniel S., et al.. (1983). D-Galactosamine Liver Injury: Absorption of Endotoxin and Protective Effect of Small Bowel and Colon Resection in Rabbits. Experimental Biology and Medicine. 172(2). 255–259. 40 indexed citations
20.
Naidich, James B., Thomas P. Naidich, Roger A. Hyman, et al.. (1979). The Big Rib Sign: Localization of Basal Pulmonary Pathology in Lateral Projection Utilizing Differential Magnification of the Two Hemithoraces. Radiology. 131(1). 1–8. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026